Viruses as vaccine vectors for infectious diseases and cancer

被引:260
作者
Draper, Simon J. [1 ]
Heeney, Jonathan L. [2 ]
机构
[1] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England
[2] Univ Cambridge, Dept Vet Med, Lab Viral Zoonot, Cambridge CB3 0ES, England
基金
美国国家卫生研究院;
关键词
T-CELL RESPONSES; PRIME-BOOST REGIMENS; BACTERIAL ARTIFICIAL CHROMOSOME; BACILLE CALMETTE-GUERIN; AVIAN INFLUENZA-VIRUS; IMMUNE-RESPONSES; ADENOVIRUS VECTORS; TUBERCULOSIS VACCINE; DENDRITIC CELLS; RHESUS-MONKEYS;
D O I
10.1038/nrmicro2240
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent developments in the use of viruses as vaccine vectors have been facilitated by a better understanding of viral biology. Advances occur as we gain greater insight into the interrelationship of viruses and the immune system. Viral-vector vaccines remain the best means to induce cellular immunity and are now showing promise for the induction of strong humoral responses. The potential benefits for global health that are offered by this field reflect the scope and utility of viruses as vaccine vectors for human and veterinary applications, with targets ranging from certain types of cancer to a vast array of infectious diseases.
引用
收藏
页码:62 / 73
页数:12
相关论文
共 137 条
[1]   A SOLUBLE RECEPTOR FOR INTERLEUKIN-1-BETA ENCODED BY VACCINIA VIRUS - A NOVEL MECHANISM OF VIRUS MODULATION OF THE HOST RESPONSE TO INFECTION [J].
ALCAMI, A ;
SMITH, GL .
CELL, 1992, 71 (01) :153-167
[2]   Commentary: New insights into the subversion of the chemokine system by poxviruses [J].
Alcami, Antonio .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (04) :880-883
[3]   A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus [J].
Alejo, A ;
Ruiz-Argüello, MB ;
Ho, Y ;
Smith, VP ;
Saraiva, M ;
Alcami, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (15) :5995-6000
[4]   The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses [J].
Antoine, G ;
Scheiflinger, F ;
Dorner, F ;
Falkner, FG .
VIROLOGY, 1998, 244 (02) :365-396
[5]   Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway [J].
Antoniou, Antony N. ;
Powis, Simon J. .
IMMUNOLOGY, 2008, 124 (01) :1-12
[6]   Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates [J].
Aurisicchio, Luigi ;
Mennuni, Carmela ;
Giannetti, Patrizia ;
Calvaruso, Francesco ;
Nuzzo, Maurizio ;
Cipriani, Barbara ;
Palombo, Fabio ;
Monaci, Paolo ;
Ciliberto, Gennaro ;
La Monica, Nicola .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (11) :2290-2300
[7]   A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya [J].
Bejon, Philip ;
Mwacharo, Jedidah ;
Kai, Oscar ;
Mwangi, Tabitha ;
Milligan, Paul ;
Todryk, Stephen ;
Keating, Sheila ;
Lang, Trudie ;
Lowe, Brett ;
Gikonyo, Caroline ;
Molyneux, Catherine ;
Fegan, Greg ;
Gilbert, Sarah C. ;
Peshu, Norbert ;
Marsh, Kevin ;
Hill, Adrian V. S. .
PLOS CLINICAL TRIALS, 2006, 1 (06)
[8]   AN EFFICIENT AND FLEXIBLE SYSTEM FOR CONSTRUCTION OF ADENOVIRUS VECTORS WITH INSERTIONS OR DELETIONS IN EARLY REGION-1 AND REGION-3 [J].
BETT, AJ ;
HADDARA, W ;
PREVEC, L ;
GRAHAM, FL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8802-8806
[9]   Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations [J].
Beveridge, Natalie E. R. ;
Price, David A. ;
Casazza, Joseph P. ;
Pathan, Ansar A. ;
Sander, Clare R. ;
Asher, Tedi E. ;
Ambrozak, David R. ;
Precopio, Melissa L. ;
Scheinberg, Phillip ;
Alder, Nicola C. ;
Roederer, Mario ;
Koup, Richard A. ;
Douek, Daniel C. ;
Hill, Adrian V. S. ;
McShane, Helen .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (11) :3089-3100
[10]  
Blair GE, 2004, CURR TOP MICROBIOL, V273, P3